Free Trial

Terumo (OTCMKTS:TRUMY) Shares Gap Up - Still a Buy?

Terumo logo with Medical background

Key Points

  • Terumo Corp. (OTCMKTS:TRUMY) shares opened at $19.60 after closing at $18.87, reflecting a significant gap up in trading.
  • The company reported earnings of $0.20 per share for the last quarter, surpassing analysts' expectations of $0.17, despite revenue falling short at $1.76 billion compared to an estimate of $1.80 billion.
  • Terumo holds a market cap of $27.92 billion and maintains a healthy financial standing with a debt-to-equity ratio of 0.12.
  • Five stocks we like better than Terumo.

Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) gapped up prior to trading on Tuesday . The stock had previously closed at $18.87, but opened at $19.60. Terumo shares last traded at $18.86, with a volume of 1,673 shares.

Terumo Stock Up 1.5%

The company has a 50 day moving average price of $17.62 and a two-hundred day moving average price of $18.23. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.00 and a quick ratio of 1.78. The stock has a market cap of $27.70 billion, a PE ratio of 32.83 and a beta of 0.80.

Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. Terumo had a return on equity of 9.30% and a net margin of 12.09%.The firm had revenue of $1.76 billion during the quarter, compared to analysts' expectations of $1.80 billion.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Read More

Should You Invest $1,000 in Terumo Right Now?

Before you consider Terumo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.

While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.